An Act relative to patient access to biomarker testing to provide appropriate therapy

This bill amends Massachusetts state law to require that the state's group insurance commission cover biomarker testing for employees and retirees. The legislation defines biomarker testing as the analysis of a patient's biological samples to identify indicators of disease or drug response and mandates coverage when such tests are supported by FDA approvals, federal Medicare decisions, or nationally recognized clinical guidelines. By establishing these specific criteria, the bill aims to ensure that insured individuals have access to necessary diagnostic tools that help doctors determine the most appropriate therapy for their conditions.